BPO 0.00% 0.3¢ bioprospect limited

further news, page-3

  1. 40 Posts.
    thanks for the tip, but am not too confident with this one. The company's portfolio is quite meagre, only around $400,000 and that's being generous. But who knows if it takes off it will be in the big time. Looks like a few biotechs are on the hopefull at this point. Pity NRT is heading south rapidly. Any news on that?
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.